Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland

Clinical trial NCT07526961 · COMPLETED

Trial details

NCT number: NCT07526961
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer

Start date: 2025-12-01
Primary completion: 2026-01-20
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.